SCHEMBL3560799

SCHEMBL3560799

CCCCN(c1ccccc1CCc1ccc(C(=O)O)cc1)S(=O)(=O)c1ccc(NC(C)=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.52
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
GAA P10253 3/20 0.49
MAPT P10636 3/20 0.49
HTT P42858 3/20 0.48
ALDH1A1 P00352 1/20 0.48
PTGES O14684 2/20 0.48
KEAP1 Q14145 2/20 0.47
NFE2L2 Q16236 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
CNR2 P34972 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA9 Q16790 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
NR3C1 P04150 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3561595 0.89 ALOX5 (0.56) ALOX5MEN1KMT2APTGESKEAP1
SCHEMBL3557378 0.89 ALOX5 (0.58) ALOX5MEN1KMT2APTGESKEAP1
SCHEMBL3564284 0.89 ALOX5 (0.58) ALOX5MEN1KMT2APTGESKEAP1
SCHEMBL3560865 0.89 ALOX5 (0.57) ALOX5MEN1KMT2AALDH1A1PTGES
SCHEMBL3554627 0.88 ALOX5 (0.57) ALOX5MEN1KMT2APTGESKEAP1
SCHEMBL3558490 0.88 ALOX5 (0.56) ALOX5MEN1KMT2APTGESKEAP1
SCHEMBL3558336 0.87 ALOX5 (0.55) ALOX5MEN1KMT2APTGESKEAP1
SCHEMBL3553929 0.86 ALOX5 (0.58) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL3554230 0.85 ALOX5 (0.60) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL3557949 0.85 ALOX5 (0.60) ALOX5MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 ALOX5 101/4885MEN1 2548/4885KMT2A 4045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.